Literature DB >> 16804564

The discovery and role of CD147 as a subunit of gamma-secretase complex.

Shuxia Zhou1, Hua Zhou, Peter J Walian, Bing K Jap.   

Abstract

Gamma-secretase is a membrane protein complex with unusual aspartyl protease activity that cleaves a variety of type I transmembrane proteins, such as APP, Notch and E-cadherin, within their transmembranous regions. Gamma-secretase was first recognized because of its role in the production of Abeta peptides that are pathogenic in Alzheimer's disease. There is overwhelming evidence demonstrating that four components, presenilin, nicastrin, APH-1 and PEN-2, are necessary and sufficient for gamma-secretase activity. However, based on the findings of studies conducted on cells overexpressing these four components, the existence of regulatory components of the gamma-secretase complex has been postulated. Recently, an additional subunit of the gamma-secretase complex, membrane protein CD147, has been identified through the purification and characterization of endogenous complexes from HeLa cell membranes. Removal of CD147 from gamma-secretase complexes increases the production of Abeta-peptides. Elucidating the molecular mechanism by which CD147 exerts its effect on the activity of the gamma-secretase complex will help us to further understand the pathogenesis of Alzheimer's disease, and may allow for the development of novel therapeutics. Copyright 2006 Prous Science. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16804564     DOI: 10.1358/dnp.2006.19.3.985932

Source DB:  PubMed          Journal:  Drug News Perspect        ISSN: 0214-0934


  7 in total

1.  Hypoxia increases amyloid-β level in exosomes by enhancing the interaction between CD147 and Hook1.

Authors:  Jun-Chao Xie; Xiao-Ye Ma; Xiao-Hui Liu; Jia Yu; Yi-Chen Zhao; Yan Tan; Xue-Yuan Liu; Yan-Xin Zhao
Journal:  Am J Transl Res       Date:  2018-01-15       Impact factor: 4.060

Review 2.  New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs.

Authors:  Salvatore Salomone; Filippo Caraci; Gian Marco Leggio; Julia Fedotova; Filippo Drago
Journal:  Br J Clin Pharmacol       Date:  2012-04       Impact factor: 4.335

3.  Solution NMR approaches for establishing specificity of weak heterodimerization of membrane proteins.

Authors:  Tiandi Zhuang; Bing K Jap; Charles R Sanders
Journal:  J Am Chem Soc       Date:  2011-11-30       Impact factor: 15.419

4.  Interaction of monocarboxylate transporter 4 with beta1-integrin and its role in cell migration.

Authors:  Shannon M Gallagher; John J Castorino; Nancy J Philp
Journal:  Am J Physiol Cell Physiol       Date:  2008-12-10       Impact factor: 4.249

Review 5.  The role of EMMPRIN in T cell biology and immunological diseases.

Authors:  Jennifer Nancy Hahn; Deepak Kumar Kaushik; V Wee Yong
Journal:  J Leukoc Biol       Date:  2015-05-14       Impact factor: 4.962

6.  Hidradenitis Suppurativa: A Perspective on Genetic Factors Involved in the Disease.

Authors:  Chiara Moltrasio; Paola Maura Tricarico; Maurizio Romagnuolo; Angelo Valerio Marzano; Sergio Crovella
Journal:  Biomedicines       Date:  2022-08-21

Review 7.  The Potential of Gamma Secretase as a Therapeutic Target for Cardiac Diseases.

Authors:  Sujoita Sen; Logan Hallee; Chi Keung Lam
Journal:  J Pers Med       Date:  2021-12-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.